Second Twitter hoax in two days, knocks off another stock

Advertisement
By Reuters | Updated: 31 January 2013 13:26 IST
Second Twitter hoax in two days, knocks off another stock
Sarepta Therapeutics Inc became the second company in as many days to see its shares plunge as a result of a Twitter hoax on Wednesday after a user posed as an influential short-seller and alleged improprieties at the biopharmaceutical company.

Sarepta Therapeutics shares plummeted 9.9 percent in a matter of seconds after someone with the Twitter user name @citreonresearc alleged improprieties at the company.

The drop mirrored a similar incident on Tuesday, when Audience Inc fell more than 25 percent following tweets that at a glance looked to be from Muddy Waters, another short-selling firm.

Just as Muddy Waters confirmed it did not send such a tweet about Audience, so too did Andrew Left, the California-based investor who runs Citron, said his company did not send a message about Sarepta.

The twin incidents targeted a pair of Nasdaq stocks that are not among the most actively traded on a daily basis, showing how certain company shares are vulnerable to information posted on social media networks, even if the information is misleading. Sarepta, on average, trades about 1.4 million shares a day; by contrast, average daily volume in chipmaker Intel Corp is about 52 million shares.

Advertisement

"You need a more volatile stock for this kind of manipulation - obviously if you were to try it on IBM it wouldn't work," said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. "It speaks to the structure of the market where shallow pools of liquidity can be easily pierced on bad news, even if the news is fake."

The U.S. Securities and Exchange Commission had no comment.

Advertisement

Twitter did not respond to an emailed request for comment on the messaging activity, but the @citreonresearc account has been suspended. The Twitter account @Mudd1waters, whose Twitter home page looks like Muddy Waters, was still active.

The tweet, with the user name "@citreonresearc," alleged that drug trial results from the biopharmaceutical company had been tainted and doctored, according to screen shots of the posting captured by Twitter users. Sarepta was not immediately available for comments on the trading activity or the account, which has since been suspended.

Advertisement

Matt, a trader in San Diego who did not want to give his last name, but who goes by the handle @given2tweet on Twitter, said, "There's a real severity to that tweet. It's at the core of what the company is, is this one trial."

Sarepta shares recovered after the brief fall. It was trading up 1.4 percent to $27.56 on volume of about 3.5 million shares in afternoon trading. More than 700,000 shares traded in the one minute when the stock suffered its steep decline.

The company, which has a market cap of about $692 million, is volatile, moving more than 1 percent in six of the past seven sessions. It jumped 477 percent in 2012 alone.

Audience went public in May 2012 and has a market cap of $254 million as of Tuesday's closing price, rising about 15 percent so far this year. The stock's 50-day average daily volume is slightly more than 160,000 shares, but that rose to more than 800,000 on Tuesday.

"Not really an efficient market when fake twitter accounts can crash stocks," Tim McClure, equity trader at SMB Capital in New York, wrote on his Twitter page.

Shares of Audience were briefly halted on Tuesday, but Sarepta shares did not reach a threshold necessary to trigger a halt. A Nasdaq spokesperson was not available for comment.

© Thomson Reuters 2013

 

For the latest tech news and reviews, follow Gadgets 360 on X, Facebook, WhatsApp, Threads and Google News. For the latest videos on gadgets and tech, subscribe to our YouTube channel. If you want to know everything about top influencers, follow our in-house Who'sThat360 on Instagram and YouTube.

Advertisement

Related Stories

Popular Mobile Brands
  1. Honor X70 With 8,300mAh Battery and Snapdragon 6 Gen 4 Launched
  2. Samsung Galaxy Z Fold 7 Said to Be Thinner Than Honor Magic V5
  3. Vivo T4R 5G to Launch Soon in India; Design Teased
  4. iPhone 17 Tipped to Get This Advanced Apple Chipset
  5. Lava Agni 4 Design, Key Specifications, and India Pricing Leaked
  6. HMD T21 Tablet With 10.36-Inch 2K Display Launched in India: Check Price
  7. OnePlus's New 2-In-1 Cable Can Charge a Smartwatch and Phone Together
  8. Portronics Beem 540 Projector Launched in India: Price, Specifications
  9. Samsung Gearing Up to Launch Three Tablets, Galaxy A17 5G Phone in India
  10. Over 75,000 Employees Fired in 2025: These Firms Conducted Mass Layoffs
  1. OnePlus 2-In-1 Charging Cable Launched; Can Charge Smartwatch, Phone Together
  2. Samsung's Galaxy Z Fold 7 Said to Be Slimmer Than the Honor Magic V5
  3. Samsung Survey Reportedly Asks Users About Future Smartphones With Qi2 Magnets
  4. Realme 15 5G to Use a MediaTek Dimensity 7300+ SoC; Camera, Display Details Tipped
  5. OpenAI Reportedly Working on ChatGPT Support for Microsoft Excel and PowerPoint-Compatible Files
  6. Chennai City Gangsters Now Streaming on Amazon Prime Video: What You Need to Know About This Tamil Comedy Drama
  7. The Girlfriend OTT Release Date: When and Where to Watch it Online?
  8. Sakamoto Days Season 1 Part 2 Now Streaming on Netflix: What You Need to Kno
  9. Google Rolls Out Free 1-Year AI Pro Subscription for Students in India: How to Get It
  10. Mistral Releases Voxtral, Its First Open-Source Speech Generation AI Models With Native Language Understanding
Gadgets 360 is available in
Download Our Apps
Available in Hindi
© Copyright Red Pixels Ventures Limited 2025. All rights reserved.